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Background: As more point of care diagnostics become available, the need to transport and store perishable
medical commodities to remote locations increases. As with other diagnostics, malaria rapid diagnostic tests (RDTs)
must be highly reliable at point of use, but exposure to adverse environmental conditions during distribution has
the potential to degrade tests and accuracy. In remote locations, poor quality diagnostics and drugs may have
significant negative health impact that is not readily detectable by routine monitoring. This study assessed
temperature and humidity throughout supply chains used to transport and store health commodities, such as RDTs.
Methods: Monitoring devices capable of recording temperature and humidity were deployed to Burkina Faso (8),
Senegal (10), Ethiopia (13) and the Philippines (6) over a 13-month period. The devices travelled through
government supply chains, usually alongside RDTs, to health facilities where RDTs are stored, distributed and used.
The recording period spanned just over a year, in order to avoid any biases related to seasonal temperature
variations.
Results: In the four countries, storage and transport temperatures regularly exceeded 30.0°C; maximum humidity
level recorded was above 94% for the four countries. In three of the four countries, temperatures recorded at
central storage facilities exceeded pharmaceutical storage standards for over 20% of the time, in another case for a
majority of the time; and sometimes exceeded storage temperatures at peripheral sites.
Conclusions: Malaria RDTs were regularly exposed to temperatures above recommended limits for many
commercially-available RDTs and other medical commodities such as drugs, but rarely exceeded the recommended
storage limits for particular products in use in these countries. The results underline the need to select RDTs, and
other commodities, according to expected field conditions, actively manage the environmental conditions in
supply chains in tropical and sub-tropical climates. This would benefit from a re-visit of current global standards on
stability of medical commodities based in tropical and sub-tropical climatic zones.
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A major challenge for health systems in the tropics and
sub-topics in the delivery of health care to remote and
rural populations is maintaining the quality of commo-
dities from time of entry to the country to time of use.
Diagnostics and drugs can be subject to prolonged sto-
rage and transport where ambient temperature and hu-
midity are high, while resources for environmental
control are limited. The accelerated increase in the use
of malaria rapid diagnostic tests (RDTs), perishable bio-
logical tests based on capture of parasite antigen by anti-
bodies (protein) stabilized on a nitro-cellulose (organic)
strip, has raised the profile of this issue within many
health services in malaria-endemic regions. While em-
phasis on the manufacture of stable tests is essential in
addressing this [1-4], understanding and managing the
subsequent transport and storage of RDTs, and match-
ing product stability to these conditions, is essential to
ensure that misdiagnosis and subsequent avoidable mor-
tality do not occur.
The WHO recommends parasitological confirmation
of malaria by microscopy or alternatively by rapid diag-
nostic tests (RDTs) in all patients suspected of malaria
before treatment initiation [5]. As most people at risk
have poor access to reliable microscopy, widespread use
of RDTs in remote, hard-to-supply areas is therefore es-
sential to implement this policy [6]. Typically, RDTs and
other health commodities arrive at a central warehouse,
from where they may be distributed to regional or dis-
trict facilities, or directly to peripheral health facilities.
Recommendations on storage and transport recommend
minimizing storage time at clinic level, but long peri-
pheral storage may be necessary to maintain adequate
safety stocks. A previous study in South East Asia
reported storage beyond RDT manufacturer limits [7].
Such temperatures have been shown to degrade some
commercially available tests [4].
Standards for registration of perishable medical com-
modities (drugs and in-vitro diagnostics) of the Inter-
national Conference on Harmonization (ICH) and the
Global Harmonization Task Force are well defined for
cooler, temperate regions (Climatic Zones I and II) [8].
For climatic Zones III (hot/dry) and IV (hot/humid),
ICH recommended a minimum stability for 1 year at
30°C and 35% humidity (Zone III) and 30°C and 65%
humidity (Zone IV) [9]. While noting the ASEAN-
recommended variant of 30°C and 75% humidity for
Zone IV [10], the WHO still endorses the former ICH
guidelines for Zones III and IV for pharmaceuticals
[11], which commonly share supply lines with diagnos-
tics. The adequacy of these standards is crucial to malaria
management, as the countries concerned are often li-
mited in their ability to control storage conditions. Fur-
thermore remoteness and limits in capacity for managingstocks often require total product life-spans of well over
the 12 months on which ICH criteria are based.
This study aimed to gather data on actual tempera-
tures and humidity levels, in different climatic zones, to
which RDTs are subjected as they move through the
supply chains that typically serve malaria-endemic
countries to assess the appropriateness of RDTs pro-
cured in each country programme in terms of thermal
stability. With the wide roll-out of RDTs in recent years
and limited capacity for quality control once RDTs are
dispersed from the central warehouse, understanding
the likely environment in which RDTs are transported
and stored is vital for procurement decisions and pa-
tient safety.
Methods
The study monitored temperature and humidity in sto-
rage facilities and health facilities in four malaria-
endemic countries: Senegal, Burkina Faso, Ethiopia, and
the Philippines. All are in ICH Climatic Zones III and IV
[8], but have a range of climatic conditions. Temperature
data collection was carried out during storage and trans-
port events occurring in selected sites in each country
during the study period. These were compared with the
manufacturer-recommended product storage tempera-
tures of each product at the time of the study.
Temperature and humidity recordings
Temperatures and humidity were recorded using elec-
tronic monitors (LogTagW HAXO-8 Humidity &
Temperature Recorder; ACR Systems, New Zealand,
Range −40°C to +85°C [± 0.5°C] and 0% to 100% RH [±
3 RH]). The monitors are equipped with a button which
enables users to record a “mark” in the data stream, with
a corresponding date and time, to be used when an
event occurs, such as when transport left, or arrived at, a
storage facility. The monitors were sent to the field in-
side envelopes with a form on the back allowing field
collaborators to record relevant events. For the purposes
of this study, LogTag monitors were either stored and
transported alongside RDTs, or placed in locations
where RDTs are routinely stored. The monitors were set
to capture temperature and humidity data every two
hours in storage facilities, while those specifically sent
with transport were programmed to record every 30 or
60 minutes. Stored data was downloaded from the Log-
Tag monitors and the mean temperatures were calcu-
lated using Microsoft Excel.
Senegal
Climate
Senegal, a coastal country extending into the arid Sahel,
has a tropical climate with dry and rainy seasons. Aver-
age annual minimum and maximum temperatures range
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inland, with a maximum temperature of around 50
degrees (National Agency of Meteorology Senegal, un-
published data, 2010).Supply chain and storage facilities
On delivery to the public sector, malaria RDTs are
stored in the National Supply Pharmacy in Dakar, a
non-air-conditioned site, prior to distribution. Temperature
and humidity were monitored in the National Supply
Pharmacy, two regional supply pharmacies, three district
pharmacies, three health posts and one health hut (the
lowest level of public-sector health care delivery). Trans-
port data (by truck, car and bicycle) was collected from
the central store to peripheral stores.Study timeline
Data was collected over 13 months, from December
2009 to January 2011.Malaria RDT
The test used in the National Malaria Control Prog-
ramme (NMCP) during the study had a manufacturer-
recommended storage temperature range from 1 to 40°C,
and was detecting HRP2 (Histine-rich protein 2) antigens
(single test line).Burkina Faso
Climate
Burkina Faso is a landlocked Sahel country with climatic
zones ranging from very arid in the north to humid in
the south, with distinct dry and rainy seasons. There is
wide variation in temperatures, with an annual range be-
tween 5°C and 47°C (Institut Géographique du Burkina,
unpublished data, 2011).Supply chain and storage facilities
Temperatures and relative humidity were monitored in
the central store (CAMEG – Centrale d’achat de Médi-
caments Essentiels Génériques) in Ouagadougou, one re-
gional store where public-sector procurement is initially
received, two health district stores, and three health cen-
ter stores. Transport data (by van and truck) was col-
lected from the central store to regional stores (3) and
from regional stores to health district stores (3). RDTs
were not kept under air-conditioning in any of these
facilities.Study timeline
Data was collected over a period of 12 months, from
August 2009 to August 2010.Malaria RDT
The RDT procured by the NMCP of Burkina Faso du-
ring the study had a recommended temperature storage
range of 1°C to 40°C; this product was targeting both
pLDH (Plasmodium lactate deshydrogenase) and HRP2
antigens (two test lines).
Ethiopia
Climate
The mean annual temperatures in Ethiopia range from
10°C to 40°C, the maximum occurring in the lowlands,
while the climate is milder in the central highlands,
much of which are malaria-free [12].
Supply chain and storage facilities
Temperature and humidity were monitored in the cen-
tral store (PFSA – Pharmaceutical Fund and Supply
Agency) in Addis Ababa where they were temporarily
stocked before distribution to three regional stores, three
health center stores and six health posts in the regions.
None of these facilities had air-conditioning.
Study timeline
Data was collected over a period of 13 months, from De-
cember 2009 to January 2011.
Malaria RDT
The two malaria RDTs in use during this study had sto-
rage recommendations of 4°C to 30°C and 4°C to 45°C,
respectively. One product targeted both pLDH and
HRP2 antigens (two test lines), while the other only
HRP2 antigen (single test line).
The Philippines
Climate
The Philippines is an island country with a tropical cli-
mate and a mean annual temperature of 26.6°C. During
the hot season, temperatures rise above 36°C [13].
Supply chains and storage facilities
Temperature and humidity were monitored at the Depart-
ment of Health Central Warehouse in Manila, in two re-
gional warehouses and at health centers in three remote
villages. None of these facilities was air-conditioned. Tem-
peratures were also recorded during transport direct from
the Central Warehouse to two villages.
Study timeline
Data was collected over a period of 15 months, from
June 2009 to September 2010.
Malaria RDT
The malaria RDTs distributed during the study had
recommended storage temperatures from 4°C to 45°C,
Table 1 Summary table of RDT storage temperatures and humidity levels
% of Temp.(°C)
Min Temp. (°C) Max Temp.(°C) Max humidity (%RH) ≤ 30.0 >30.0 >37.0 >40.0 >45.0
Burkina Faso 13.6 42.7 100
Bobo Dioulasso -Regional Warehouse 17.1 35.5 80 61.6 38.4 0.0 0.0 0.0
Dori -Health District 24.2 42.7 73 21.1 78.9 16.3 3.9 0.0
Dori-Health Center 24.2 41.3 83 26.6 73.4 11.8 1.5 0.0
Gaoua -Health District 13.6 39.4 100 45.5 54.5 0.1 0.0 0.0
Gaoua -Health Center 18.8 35.9 100 74.4 25.6 0.0 0.0 0.0
Nouna -Health District 17.4 34.9 80 93.8 6.2 0.0 0.0 0.0
Nouna -Health Center 20.7 41.8 93 38.8 61.2 10.0 1.2 0.0
Ouagadougou -Central Warehouse 26.2 34 82 52.3 47.7 0.0 0.0 0.0
Philippines 21.2 36.4 100
Cawag, Subic, Zambales City -Health Facility 21.2 36.4 100 79.9 20.1 0.0 0.0 0.0
Manila -Central Warehouse 24.7 34.2 99 76.3 23.7 0.0 0.0 0.0
Palawan -Health Facility 23.9 35.8 100 72.9 27.1 0.0 0.0 0.0
Quezon -Regional Warehouse 23.4 33.6 84 73.0 27.0 0.0 0.0 0.0
Quezon -Health Facility 21.9 36.1 98 86.4 13.5 0.0 0.0 0.0
Tuguegarao -Regional Warehouse 22.6 36.4 86 63.7 36.3 0.0 0.0 0.0
Senegal 19.2 47.6 99
Guédiawaye -District Pharmacy 23.9 32.4 83 76.0 24.0 0.0 0.0 0.0
Dakar -National Warehouse 20.9 31.3 95 96.9 3.1 0.0 0.0 0.0
Kolda -Regional warehouse 19.2 38.3 78 66.9 33.1 1.3 0.0 0.0
Kounkané -Pharmacy/Health post 20.6 37.4 92 59.5 40.5 0.1 0.0 0.0
Lingéwal -Pharmacy/Health post 21.5 40.9 99 51.7 48.3 3.8 0.1 0.0
Matam -District Pharmacy 25.4 40.3 75 16.0 84.0 11.4 0.1 0.0
Nabadaji -Pharmacy/Health post 23.1 47.6 71 10.7 89.3 38.7 18.2 1.8
Nimzatt -Health Post 22.6 34.6 85 69.2 30.8 0.1 0.0 0.0
Ourrossogui -Regional warehouse 22.4 41.8 86 21.4 78.6 17.0 1.4 0.0
Velingara -District Pharmacy 22.6 41.1 95 34.8 65.2 9.1 0.6 0.0
Ethiopia 8.3 43.7 94
Afar-Health center (C11) 24.9 43.7 67 19.7 80.3 28.6 7.6 0.0
Afar-Health post (C21) 22.0 41.1* 83 43.6 56.4 3.7 0.0 0.0
Afar-Health post 25.1 40.9 67 23.8 76.2 14.0 1.0 0.0
Afar-Regional Warehouse 23.3 42.2* 73 21.1 79.0 1.6 0.0 0.0
Amhara-Health post 14.7 32.7 88 99.1 0.9 0.0 0.0 0.0
Amhara-Health post 16.8 32.5 82 100.0 0.0 0.0 0.0 0.0
Amhara-Regional Warehouse 17.3 31.3 72 99.0 1.0 0.0 0.0 0.0
Amara-Health center 19.5 29.6 81 100.0 0.0 0.0 0.0 0.0
Oromia-Central Warehouse 8.3 33 94 99.1 0.9 0.0 0.0 0.0
Oromia-Regional Warehouse 16.6 33.3 71 100.0 0.0 0.0 0.0 0.0
Oromia-Health post (C13) 17.6 30.8 85 100.0 0.0 0.0 0.0 0.0
Oromia-Health post (C15) 17 31.6 86 100.0 0.0 0.0 0.0 0.0
Oromia-Health center 16.2 29.3 85 100.0 0.0 0.0 0.0 0.0
* Only one single temperature reading recorded above 40°C.
The temperature ranges were based on manufacturer-recommended storage temperatures for the RDTs used in this study. Percentages of temperature recorded
above the recommended limit for the RDTs uses in the country are highlighted in italics.
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HRP2 antigen (single test line), and the other both aldo-
lase and HRP2 antigens (two test lines).
Results
Storage data
Considerable variation was recorded in temperatures
throughout the commodity supply chain, with tempera-
tures ranging from 8.3°C to 47.6°C and a maximum hu-
midity recorded of 100% (± 3 RH). Data are summarized
in Table 1.
Senegal
Temperatures ranged from 19.2°C to 47.6°C. In three fa-
cilities, at the regional, district level and health center
level (in the regions of Matam, Nabadaji, and Ourosso-
gui respectively), temperatures greater than 30.0°C were
recorded for more than 70.0% of the time. At the central















Senegal : Ourrossogui Regional warehouse
Max Temp. (°C)
Figure 1 Storage temperatures across study period at 2 facilities in Swere recorded 96.9% of the time. Temperatures were
also reported to be higher in the Kolda regional ware-
house than in the pharmacy of Kounkané, and reached a
maximum of 38.3°C and 37.4°C respectively.
Temperatures were particularly high at the Ourossogui
regional warehouse (maximum 41.8°C) and Nabadaji
Pharmacy and Health Center (maximum 47.6°C), where
temperatures above 30.0°C were recorded every week
(Figure 1). Each threshold line (red lines) indicated in
figures 1 and 2 represents one of the manufacturer-
recommended storage temperatures for the RDTs used
in this study (30, 37, 40, 45°C).Burkina Faso
Temperatures ranged from 13.6°C to 42.7°C. In two fa-
cilities, the health district level and health centre level in
the region of Dori, temperatures higher than 37.0°C were
recorded for more than 11.8% of the total storage time.
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enegal.
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time. In Gaoua, temperatures were higher in the health
district than in the more peripheral health centers, with
maximums of 39.4°C and 35.9°C respectively.
Ethiopia
Temperatures ranged from 8.3°C to 43.7°C. In two faci-
lities, at health center and health post level in the region
of Afar, temperatures over 40.0°C were recorded. At the
central warehouse level in Addis, temperatures were
over 30.0°C for 0.9 % of the time. In Oromia and Afar
regions, higher temperatures were reported at the cen-
tral and regional warehouses than at the heath post level.
Temperatures were particularly high in Afar region
where temperatures above 37.0°C were recorded over
several weeks between April and October in two health
centers (Figure 2).
The Philippines
Temperatures ranged from 21.2°C to 36.4°C. At the cen-
tral warehouse level in Manila, temperatures higher than















Ethiopia : Afar Health Center (Assayta, C11)  
Figure 2 Storage temperatures across study period at 2 facilities in EComparison with manufacturer-recommended
temperatures
In Burkina Faso, Senegal and Ethiopia storage tempera-
tures exceeded the recommended RDT manufacturer
temperature limits. In three out of eight facilities (one
health district facility and two health centres) in Burkina
Faso, temperatures rose above the recommended RDT
manufacturer temperature limit of 40°C. In 11 out of 13
facilities in Ethiopia (one health center, six health posts,
two central warehouses, two regional warehouses), tem-
peratures exceeded the recommended RDT manufac-
turer temperature limit of 30°C, up to 80.3% of time at
one site. In five out of ten facilities in Senegal (one re-
gional warehouse, two district pharmacies, two pharma-
cies/health post), temperatures rose above the
recommended RDT manufacturer temperature limit of
40°C, 18.2% of the time in one site (Table 1).
Humidity
All RDTs are sealed in foiled packages and should not
been exposed to humidity before use, although humidity
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from 94 to 100% RH (Table 1).
Transport data
Thirty transport chains were recorded for the three
countries (Senegal, Burkina Faso, and the Philippines).
From the national to the regional warehouse level, two
different transport chains were recorded in Senegal and
each transport took 25 hours (minimum 27.3°C, max-
imum 38.8°C). In Burkina Faso, nine different transport
chains occurred and transport took between three to
nine hours (minimum 24.4°C, maximum 43°C). In the
Philippines, three transport episodes were recorded from
the central and regional warehouses to health centers in
Palawan, Mindoro and Tuguegarao. These involved both
road and air conveyances. In all three cases, the average
temperature remained within acceptable limits (mini-
mum 22.1°C, maximum 29.1°C), with the exception of
one transport chain segment where the maximum
temperature rose to 41.5°C. Data for all the transport
chains are presented in Table 2.
Discussion
The malaria rapid diagnostic tests monitored in this
study were exposed to conditions above manufacturer
recommendations in three of the four countries studied,Table 2 Transport chain conditions
Transport chains (n) Temperature range (°
Senegal
National-Regional warehouse (2) 27.3-38.8
Regional warehouse-Sanitary district (1) 31.6-34.4
Sanitary district-Health post level (1) 31.0 (1 reading only)
Health post level-health hut level (2) 31.1-42.9
Burkina Faso
Central-Regional warehouse (9) 24.4-43
Regional warehouse-health district level (7) 26.6-41.0 (no cool chain
−3.6-32 (cool chain)
Health district-health center (4) 26.6-41.7
The Philippines
Central-Regional warehouse-health center (3) 22.1-41.5
Regional warehouse-village Health center (1) 24.6-32though for only brief periods. However, in all countries,
conditions within these supply lines were above 30°C for
considerable periods- beyond the WHO recommenda-
tions for stability of pharmaceuticals that are delivered
through similar supply chains [11], and thus for many
other commercially-available malaria RDTs. While the
countries appear to have selected RDTs with stated sta-
bility, in keeping with general transport and storage con-
ditions in this limited survey, the results raise questions
over adequacy of supply line management for other
medical commodities. In the four countries, drugs and
RDTs are stored under the same conditions; this illus-
trates the importance of understanding transport and
storage conditions in RDT product selection [14].
Whether the periods of temperature exposure
recorded here affect RDT quality depends on the stabi-
lity of the individual products. Previous studies have
shown a high variability in RDT stability, both for HRP2
detecting test lines and particularly for test lines detect-
ing pLDH [1-4]. Stability can vary at times between lots
of specific products [1,3,15], but real-time stability data
on a range of products lot-tested through the WHO-
FIND malaria RDT evaluation programme suggests that
significant failures in tests stored within manufacturer
recommendations are not common [16]. The products
in use by public health services in the countries involvedC) Transport duration (time) Comments
25 hours _No cool chain system
_Truck
2 hours _ No cool chain system
_Car
1 hour _ No cool chain system
_Car
4-6 hours _ No cool chain system
_Bicycle
3-9 hours _No cool chain system
_Truck
) 3-9 hours _No cool chain system (8)
_Truck
3-9 hours _No cool chain system
_Van
10-17 days _No cool chain system
_road and air conveyance
1 hour _No cool chain system
_Van
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ranging from 40°C to 45°C, well above the former ICH
recommendations, but only exceeded these temperatures
for relatively short periods of time. However, these tem-
peratures are above the recommendations for many
other malaria RDTs; only 13 of the 50 RDTs tested in
the Round 3 of the WHO Product Testing Programme
had recommended storage temperatures of 40°C or
above (FIND, unpublished data).
Other commodities (with the exception of vaccines)
are generally stored together in the same facilities at
central, regional, and peripheral levels. For example,
certain tablet formulations of anti-malarials (e.g.,
artemether-lumefantrine, artesunate, amodiaquine, sul-
phadoxine, pyrimethamine), and HIV antiretrovirals (e.g.,
lopinavir, ritonavir) listed as essential drugs should not
be stored above 30°C [17].
These data raise a number of issues. Firstly, diagnostics
(and drugs) clearly need to be selected taking into ac-
count the expected exposure to heat and humidity.
While humidity is normally addressed by the moisture-
proof packaging in which the product is delivered, mea-
suring temperature using electronic monitors is rela-
tively easy and cheap. This knowledge should inform
procurement criteria. As openly-available data on real-
time stability is limited, it seems advisable for countries
to require real-time heat stability data from manufac-
turers on which product storage recommendations
should be based. It has been recommended to store
RDTs at a central level for as long as possible on the as-
sumption that peripheral storage is less controlled [18].
High temperatures recorded at central facilities in the
four countries suggest that logistics planning should take
actual storage data into account, and that managing con-
ditions at central storage facilities should be taken more
seriously. While storage standards for in-vitro diagnostic
are less well defined, WHO standards for temperature
stability of pharmaceuticals were exceeded at central
storage over 23% of the time in two countries [11].
Clearly, published standards for pharmaceuticals and
diagnostics in these climatic conditions are inadequate.
Without substantial resources devoted to controlled
transport and storage, temperatures of 30°C are rou-
tinely exceeded. There does appear to be a case here for
investment in temperature control of central medical
storage facilities. However, RDTs are a relatively high
volume commodity, making controlled-temperature
transport and storage at remote locations often impracti-
cal. Refrigeration is unnecessary for current products,
and can also pose some risks, as shown in this study
where one RDT was exposed to temperatures below
−3°C in Burkina Faso. RDT storage outside the
manufacturer-recommended temperature could shorten
RDT product shelf life, yet this is difficult to detect.When RDTs are known to have been subjected to ex-
treme conditions for some time, re-testing a batch
withdrawn from the field against parasite panels is pos-
sible (e.g. lot testing laboratories in the Philippines and
in Cambodia, [19], or comparing with microscopy, but
both can be logistically difficult. Rejecting a batch on
the basis of transport conditions without evidence of
poor performance is costly. The development of positive
control wells, based on lyophilized parasite antigens, holds
promise to address clinic-level quality control dilemmas
for malaria RDTs [20].
Lower cost solutions are available for remote-area sto-
rage, such as underground storage or the use of evapora-
tive cooler boxes [21]. Storage using evaporative cooling
has been demonstrated for malaria RDTs in Afghanistan
[22] and Cambodia [23], reducing temperatures from as
much as 37°C to 23°C without use of electricity, well
within the common range for storage of non-vaccine
medical commodities. Moreover, simple measures during
transport, such as loading and discharging vehicles in
the shade or at night, reduce the probability of deterio-
ration [21,24]. In the end, the performance of the pro-
duct at end-user level is the most important measure
of impact of previous environmental damage; this is
difficult to sustain for both diagnostics and drugs. Whereas
this is currently being addressed for malaria, monitoring
the availability of the active ingredient of a drug in a re-
mote location is likely to remain a major challenge.
Due to the complexities of coordinating logistics
throughout transport chains, only segments of the trans-
port chain were recorded in this study. A larger study
would likely reveal a wider range of conditions and pro-
blems. Since only a small sample of transport and sto-
rage was collected in each country, the results cannot be
considered fully representative of the conditions under
which medical commodities are transported and stored
in any of these countries. However, they illustrate the
lack of control in supply chains and potential for envir-
onmental damage of products. Ideally, the condition of
RDTs should also have been tested; the countries con-
cerned procure RDTs with relatively high recommended
maximum storage temperatures so it is unclear whether
the relatively short periods when they are exposed to
higher temperatures would have been significant. How-
ever, the study results raise concern with respect to RDT
stability between production lots (pre-release real-time
testing of production lots is obviously not possible [1,3],
as well as the effect of their co-storage with other per-
ishable medical commodities, as discussed above.
Conclusion
Transport and storage temperatures varied widely
throughout the supply chains monitored here. In par-
ticular high temperatures were recorded at central
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mended storage conditions of the RDTs used by these
health services were rarely exceeded, conditions were in-
appropriate for many of the RDTs on the market and
frequently exceeded common pharmaceutical storage
standards. A number of simple measures can be insti-
tuted to lower ambient temperatures, and tests for com-
modity quality control are clearly needed. The results
illustrate the importance of health services understand-
ing their supply chain conditions and matching product
procurement to these. They also suggest that a revisit of
standards is indicated for medical commodities in gen-
eral in the tropics and sub-tropics, as existing standards
for Climatic Zones III and IV appear inadequate on the
basis of this study.
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